{"Osimertinib": [0], "is": [1], "a": [2], "third-generation,": [3], "irreversible": [4], "tyrosine": [5], "kinase": [6], "inhibitor": [7], "of": [8, 71], "the": [9, 55, 68], "epidermal": [10], "growth": [11], "factor": [12], "receptor": [13], "(EGFR-TKI)": [14], "that": [15], "selectively": [16], "inhibits": [17], "both": [18], "EGFR-TKI\u2013sensitizing": [19], "and": [20], "EGFR": [21, 38], "T790M": [22], "resistance": [23], "mutations.": [24], "A": [25], "phase": [26], "3": [27], "trial": [28, 46], "compared": [29], "first-line": [30], "osimertinib": [31, 52], "with": [32, 37, 51, 54], "other": [33], "EGFR-TKIs": [34, 57], "in": [35], "patients": [36], "mutation\u2013positive": [39], "advanced": [40], "non\u2013small-cell": [41], "lung": [42], "cancer": [43], "(NSCLC).": [44], "The": [45], "showed": [47], "longer": [48], "progression-free": [49], "survival": [50, 73], "than": [53], "comparator": [56], "(hazard": [58], "ratio": [59], "for": [60], "disease": [61], "progression": [62], "or": [63], "death,": [64], "0.46).": [65], "Data": [66], "from": [67], "final": [69], "analysis": [70], "overall": [72], "have": [74], "not": [75], "been": [76], "reported.": [77]}